Trials / Completed
CompletedNCT00340054
Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
Assessment of Occupational EMF Exposure - Validation of Interview Procedures Used in Brain Tumor Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 108 (estimated)
- Sponsor
- National Institutes of Health Clinical Center (CC) · NIH
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Electric and magnetic fields may increase the risk of cancer. Developing interview questions that accurately estimate a person's exposure to electric and magnetic fields may help doctors learn about the long-term effects of workplace exposure. PURPOSE: This clinical trial is developing interview questions that can be used in estimating workplace exposure to electric and magnetic fields.
Detailed description
OBJECTIVES: * Validate an interview-based electric and magnetic field exposure (EMF) assessment algorithm against measurements of the time-weighted average magnetic field magnitude used in previous epidemiologic studies. * Calibrate the parameters in the algorithm in order to improve the exposure estimates. * Correlate EMF exposure estimates from the algorithm with biologically based metrics measured by new instrumentation. OUTLINE: Participants respond to questions during a 5- to 15-minute telephone interview concerning workplace exposure to electric and magnetic (EMF) fields. Data is collected during the interview using an exposure assessment algorithm designed to estimate EMF workplace exposure based on participants' responses. The interview-based estimates are then validated against actual field measurements of magnetic field exposure captured by Emdex multiwave monitors located at participating sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire administration | |
| PROCEDURE | study of high risk factors |
Timeline
- Start date
- 2005-10-01
- Completion
- 2007-03-01
- First posted
- 2006-06-21
- Last updated
- 2012-03-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00340054. Inclusion in this directory is not an endorsement.